Neonatal Hyperbilirubinemia
44
7
9
21
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 44 trials
100.0%
+13.5% vs benchmark
11%
5 trials in Phase 3/4
5%
1 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (44)
Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
Effectiveness of Aluminum Foil vs White Linen Reflectors in Phototherapy for Neonatal Hyperbilirubinemia
Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management
Newborn Jaundice - An Investigation of Different Approaches to Light Therapy
Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit
White Reflective Drape in Phototherapy for Neonatal Hyperbilirubinemia
The Effect of Total Body Massage on Neonatal Jaundice in Preterm Neonates
Massage, Tub Bathing, and Sponge Bathing Effects on Neonatal Bilirubin and Comfort
Accuracy of TcB Measurements During and After Phototherapy
Wireless Irradiance SEnsors During Neonatal Phototherapy
Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
Transcutaneous Bilirubinometry and Phototherapy
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia Cohort
Parental Participation on the Neonatal Ward - the neoPARTNER Study
Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia
The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates